• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Heparin fractions with high and low affinities to antithrombin III are cleared at different rates.

作者信息

Caranobe C, Petitou M, Dupouy D, Gabaig A M, Sié P, Buchanan M R, Boneu B

出版信息

Thromb Res. 1986 Sep 15;43(6):635-41. doi: 10.1016/0049-3848(86)90100-3.

DOI:10.1016/0049-3848(86)90100-3
PMID:3764809
Abstract

The clearance characteristics of standard heparin (SH) and its fractions with high and low affinity to antithrombin III (HAH and LAH respectively) were studied by injecting 125I-labelled SH, HAH and LAH intravenously into the rabbits in increasing doses. Serial blood samples were then collected from an indwelling cannula for measurement of clearance, based both on radioactivity and anticoagulant activity. For equivalent weights injected, the radioactivity of HAH was cleared more slowly from the circulation than that of either SH or LAH. The radioactivity of SH, in turn, was cleared more slowly than that of LAH. The clearance of HAH, measured both by radioactivity and by anticoagulant activity were similar, whereas the clearance of the radioactivity of SH was more rapid than its anticoagulant activity (i.e. anti-factor Xa activity). These observations suggest that the radioactivity clearance curves of SH reflect a "net" estimation of the more complex clearance curves of the different heparin moieties whereas the anticoagulant clearance curves of SH reflects the clearance of the anticoagulant activity of a specific heparin fraction, in this case, the clearance of the anti-factor Xa activity of HAH. These differences suggest that the HAH:LAH ratio is, at any given time, greater in vivo than the same ratio measured in vitro.

摘要

相似文献

1
Heparin fractions with high and low affinities to antithrombin III are cleared at different rates.
Thromb Res. 1986 Sep 15;43(6):635-41. doi: 10.1016/0049-3848(86)90100-3.
2
Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparins.
Semin Thromb Hemost. 1995;21(2):193-200. doi: 10.1055/s-2007-1000395.
3
Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement.低亲和力肝素加速抗凝血酶-蛋白酶反应的机制。抗凝血酶结合五糖在肝素加速反应速率中的作用。
J Biol Chem. 1995 Apr 21;270(16):9043-51. doi: 10.1074/jbc.270.16.9043.
4
The disappearance of a low molecular weight heparin fraction (CY 216) differs from standard heparin in rabbits.低分子量肝素组分(CY 216)在兔体内的消除情况与标准肝素不同。
Thromb Res. 1987 Jun 15;46(6):845-53. doi: 10.1016/0049-3848(87)90076-4.
5
Evidence for a saturable mechanism of disappearance of standard heparin in rabbits.家兔体内标准肝素消失的可饱和机制的证据。
Thromb Res. 1987 Jun 15;46(6):835-44. doi: 10.1016/0049-3848(87)90075-2.
6
Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.来自不同动物来源的肝素制剂的抗凝特性,对抗凝血酶III具有同等高亲和力。
J Biochem. 1984 Mar;95(3):619-26. doi: 10.1093/oxfordjournals.jbchem.a134650.
7
Elimination of high affinity heparin fractions and their anticoagulant and lipase activity.高亲和力肝素组分及其抗凝和脂肪酶活性的消除。
Blood. 1984 Apr;63(4):836-42.
8
High and low affinity heparin compared with unfractionated heparin as antithrombotic drugs.
Thromb Haemost. 1984 Apr 30;51(2):254-6.
9
Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III.兔体内内皮细胞高亲和力结合位点对循环中凝血酶的清除作用。抗凝血酶III使凝血酶失活的可能机制。
J Clin Invest. 1980 Dec;66(6):1222-30. doi: 10.1172/JCI109973.
10
Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
Thromb Haemost. 1983 Apr 28;49(2):109-15.

引用本文的文献

1
Tinzaparin-a review of its molecular profile, pharmacology, special properties, and clinical uses.亭扎肝素——其分子特性、药理学、特殊性质和临床应用的综述。
Eur J Clin Pharmacol. 2022 Oct;78(10):1555-1565. doi: 10.1007/s00228-022-03365-4. Epub 2022 Jul 23.
2
Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?肺栓塞患者的初始抗凝治疗:溶栓、普通肝素、低分子肝素、磺达肝癸钠还是 DOACs?
Br J Clin Pharmacol. 2017 Nov;83(11):2356-2366. doi: 10.1111/bcp.13340. Epub 2017 Jul 9.
3
Tinzaparin and other low-molecular-weight heparins: what is the evidence for differential dependence on renal clearance?
亭扎肝素和其他低分子肝素:有何证据表明它们对肾脏清除率的依赖存在差异?
Exp Hematol Oncol. 2013 Aug 8;2:21. doi: 10.1186/2162-3619-2-21. eCollection 2013.
4
The pharmacokinetics of dermatan sulphate MF701 in healthy human volunteers.硫酸皮肤素MF701在健康人类志愿者体内的药代动力学。
Br J Clin Pharmacol. 1991 Sep;32(3):361-6. doi: 10.1111/j.1365-2125.1991.tb03912.x.
5
Heparin pharmacokinetics and pharmacodynamics.肝素的药代动力学和药效学。
Clin Pharmacokinet. 1992 May;22(5):359-74. doi: 10.2165/00003088-199222050-00003.